Atlas Trials

Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose Tolerance

Clinical trial NCT03980730 · TERMINATED

Trial details

NCT number
NCT03980730
Sponsor
vTv Therapeutics
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2019-06-27
Primary completion
2020-12-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.